Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

9
results for

"Young Nyun Park"

Article category

Keywords

Publication year

"Young Nyun Park"

Erratum

Hepatic neoplasm

Erratum to ‘Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial’ [Clin Mol Hepatol 2024;30:807-823]
Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, Bohwa Sohn, Yun Seong Jeong, Sang-Hee Kang, Kena Park, Hyewon Park, Sunyoung S. Lee, Ahmed O. Kaseb, Young Nyun Park, Sun-Hee Leem, Michael A. Curran, Ji Hoon Kim, Ju-Seog Lee
Clin Mol Hepatol 2025;31(2):669-670.
Published online February 27, 2025
DOI: https://doi.org/10.3350/cmh.2024.0333e
Corrects: Clin Mol Hepatol 2024;30(4):807
  • 5,378 View
  • 49 Download

Original Articles

Hepatic neoplasm

Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial
Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, Bohwa Sohn, Yun Seong Jeong, Sang-Hee Kang, Kena Park, Hyewon Park, Sunyoung S. Lee, Ahmed O. Kaseb, Young Nyun Park, Sun-Hee Leem, Michael A. Curran, Ji Hoon Kim, Ju-Seog Lee
Clin Mol Hepatol 2024;30(4):807-823.
Published online July 23, 2024
DOI: https://doi.org/10.3350/cmh.2024.0333
Background/Aims
Combination immunotherapy, exemplified by atezolizumab plus bevacizumab, has become the standard of care for inoperable hepatocellular carcinoma (HCC). However, the lack of predictive biomarkers and limited understanding of response mechanisms remain a challenge.
Methods
Using data from the IMbrave150plus cohort, we applied an immune signature score (ISS) predictor to stratify HCC patients treated with atezolizumab plus bevacizumab or with sorafenib alone into potential high and low response groups. By applying multiple statistical approaches including a Bayesian covariate prediction algorithm, we refined the signature to 10 key genes (ISS10) for clinical use while maintaining similar predictive power to the full model. We further validated ISS10 in an independent HCC cohort treated with nivolumab plus ipilimumab.
Results
The study identified a significant association between the ISS and treatment response. Among patients classified as high responders, those treated with the atezolizumab plus bevacizumab combination exhibited improved overall and progression-free survival as well as better
objective
response rate compared to those treated with sorafenib. We also observed a significant correlation between ISS10 and response to nivolumab plus ipilimumab treatment. Analysis of immune cell subpopulations revealed distinct characteristics associated with ISS subtypes. In particular, the ISS10 high subtype displayed a more favorable immune environment with higher proportions of antitumor macrophages and activated T-cells, potentially explaining its better response.
Conclusions
Our study suggests that ISS and ISS10 are promising predictive biomarkers for enhanced therapeutic outcomes in HCC patients undergoing combination immunotherapy. These markers are crucial for refining patient stratification and personalized treatment approaches to advance the effectiveness of standard-of-care regimens.

Citations

Citations to this article as recorded by  Crossref logo
  • Targeting TIME in advanced hepatocellular carcinoma: Mechanisms of drug resistance and treatment strategies
    Xinyi Ye, Xizhu Fang, Fangfang Li, Dan Jin
    Critical Reviews in Oncology/Hematology.2025; 211: 104735.     CrossRef
  • Differential Infiltration of T-Cell Populations in Tumor and Liver Tissues Predicts Recurrence-Free Survival in Surgically Resected Hepatocellular Carcinoma
    Eun Ji Jang, Ho Joong Choi, Young Kyoung You, Deok Hwa Seo, Mi Hyun Kwon, Keungmo Yang, Jaejun Lee, Jeong Won Jang, Seung Kew Yoon, Ji Won Han, Pil Soo Sung
    Cancers.2025; 17(9): 1548.     CrossRef
  • Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
    Meiyin Zhang, Chaojun Liu, Jing Tu, Min Tang, Milad Ashrafizadeh, Noushin Nabavi, Gautam Sethi, Peiqing Zhao, Shijian Liu
    Molecular Cancer.2025;[Epub]     CrossRef
  • Management and Outcomes of Adverse Events Following Immune Checkpoint Inhibitor Treatment in Patients with Hepatocellular Carcinoma
    Soon Kyu Lee, Bo Hyun Kim
    Journal of Digestive Cancer Research.2025; 13(1): 65.     CrossRef
  • Managing hepatocellular carcinoma recurrence after liver transplantation: emerging role of immune checkpoint inhibitors
    Mohammad Saeid Rezaee-Zavareh, Soo Young Hwang, Naomy Kim, Hasmik Adetyan, Nguyen H. Tran, Ju Dong Yang
    Discover Oncology.2025;[Epub]     CrossRef
  • Hepatic Metabolic Signature and Its Association with the Response to Immunotherapy in Hepatocellular Carcinoma
    Hyewon Park, Sowon Park, Kena Park, Sun Young Yim, Ju-Seog Lee, Sung Hwan Lee
    ImmunoTargets and Therapy.2025; Volume 14: 787.     CrossRef
  • Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab–bevacizumab
    Heechul Nam, Dong Yun Kim, Do Young Kim, Ji Hoon Kim, Chang Wook Kim, Jaejun Lee, Keungmo Yang, Ji Won Han, Pil Soo Sung, Seung Kew Yoon, Hee Sun Cho, Hyun Yang, Si Hyun Bae, Soon Kyu Lee, Jung Hyun Kwon, Soon Woo Nam, Ahlim Lee, Do Seon Song, U Im Chang,
    Hepatology.2025;[Epub]     CrossRef
  • Bulk and Single-Cell Transcriptomes Reveal Exhausted Signature in Prognosis of Hepatocellular Carcinoma
    Ruixin Chun, Haisen Ni, Ziyi Zhao, Chunlong Zhang
    Genes.2025; 16(9): 1034.     CrossRef
  • Efficacy and Safety of Different Doses of Bevacizumab Combined with Atezolizumab in Unresectable Hepatocellular Carcinoma
    Shaobo Zhang, Jiabei Wang, Zebin Zhu, Peng Ji, Yanli Wang, Kun Cheng, Björn Nashan, Lianxin Liu, Shugeng Zhang
    Journal of Hepatocellular Carcinoma.2025; Volume 12: 2007.     CrossRef
  • Ultrasounic-radiomics models for predicting the response to Atezolizumab plus Bevacizumab in patients with unresectable hepatocellular carcinoma
    Yiran Li, Zonghan Liu, Yi Qian, Kang Wang, Yijun Gu, Yan Chen, Haozheng Jiang, Shuqun Cheng, Dong Jiang, Xinjun Lu
    PLOS One.2025; 20(10): e0334099.     CrossRef
  • An Early Increase in IL-10 and TNF-α Levels Following Atezolizumab Plus Bevacizumab Treatment Predicts Survival in Advanced Hepatocellular Carcinoma Patients: A Prospective Cohort Study
    Soon Kyu Lee, Soon Woo Nam, Ji Won Han, Jung Hyun Kwon
    Cancers.2024; 16(20): 3543.     CrossRef
  • From biomarker discovery to combined therapies: Advancing hepatocellular carcinoma treatment strategies
    Mo-Wei Kong, Yang Yu, Ying Wan, Yu Gao, Chun-Xiang Zhang
    World Journal of Gastrointestinal Oncology.2024; 16(11): 4518.     CrossRef
  • 10,549 View
  • 385 Download
  • 18 Web of Science
  • Crossref

Hepatic neoplasm

Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection
Hye Soo Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Young Nyun Park, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Gi Hong Choi, Hyon-Suk Kim
Clin Mol Hepatol 2020;26(1):33-44.
Published online June 27, 2019
DOI: https://doi.org/10.3350/cmh.2018.0073
Background/Aims
To investigate whether serum Wisteria floribunda agglutinin-positive human Mac-2-binding protein (WFA+-M2BP) can predict the recurrence of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) after curative resection.
Methods
Patients with chronic hepatitis B (CHB) who underwent curative resection for HCC between 2004 and 2015 were eligible for the study. Recurrence was sub-classified as early (<2 years) or late (≥2 years).
Results
A total of 170 patients with CHB were selected. During the follow-up period (median, 22.6 months), 64 (37.6%) patients developed recurrence. In multivariate analyses, WFA+-M2BP level was an independent predictor of overall (hazard ratio [HR]=1.490), early (HR=1.667), and late recurrence (HR=1.416), together with male sex, des-gamma carboxyprothrombin level, maximal tumor size, portal vein invasion, and satellite nodules (all P<0.05). However, WFA+- M2BP level was not predictive of grade B-C posthepatectomy liver failure. The cutoff value that maximized the sum of sensitivity (30.2%) and specificity (90.6%) was 2.14 (area under receiver operating characteristic curve=0.632, P=0.010). Patients with a WFA+-M2BP level >2.14 experienced recurrence more frequently than those with a WFA+-M2BP level ≤2.14 (P=0.011 by log-rank test), and had poorer postoperative outcomes than those with a WFA+-M2BP level ≤2.14 in terms of overall recurrence (56.0 vs. 34.5%, P=0.047) and early recurrence (52.0 vs. 20.7%, P=0.001).
Conclusions
WFA+-M2BP level is an independent predictive factor of HBV-related HCC recurrence after curative resection. Further studies should investigate incorporation of WFA+-M2BP level into tailored postoperative surveillance strategies for patients with CHB.

Citations

Citations to this article as recorded by  Crossref logo
  • Glycomics as prognostic biomarkers of hepatocellular carcinoma: A systematic review
    Nicky Somers, Emma Butaye, Lorenz Grossar, Nele Pauwels, Anja Geerts, Sarah Raevens, Sander Lefere, Lindsey Devisscher, Leander Meuris, Nico Callewaert, Hans Van Vlierberghe, Xavier Verhelst
    Oncology Letters.2024;[Epub]     CrossRef
  • Prognostic value of preoperative systemic immune-inflammation index/albumin for patients with hepatocellular carcinoma undergoing curative resection
    Kun-Lin Chen, Yi-Wen Qiu, Ming Yang, Tao Wang, Yi Yang, Hai-Zhou Qiu, Ting Sun, Wen-Tao Wang
    World Journal of Gastroenterology.2024; 30(48): 5130.     CrossRef
  • Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study
    Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
    European Journal of Internal Medicine.2023; 107: 66.     CrossRef
  • Comparable Mortality Between Asian Patients with Chronic Hepatitis B Under Long-Term Antiviral Therapy vs Matched Control: A Population-Based Study
    Byungyoon Yun, Juyeon Oh, Sang Hoon Ahn, Jin-Ha Yoon, Beom Kyung Kim
    American Journal of Gastroenterology.2023; 118(6): 1001.     CrossRef
  • Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis
    Daniel Q. Huang, Nobuharu Tamaki, Hyung Woong Lee, Soo Young Park, Yu Rim Lee, Hye Won Lee, Seng Gee Lim, Tae Seop Lim, Masayuki Kurosaki, Hiroyuki Marusawa, Toshie Mashiba, Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Namiki Izumi,
    Hepatology.2023; 77(5): 1746.     CrossRef
  • Perioperative predictors of outcome of hepatectomy for HBV-related hepatocellular carcinoma
    Ziming He, Di Tang
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Serum wisteria floribunda agglutinin-positive human Mac-2 binding protein is unsuitable as a diagnostic marker of occult hepatocellular carcinoma in end-stage liver cirrhosis
    Kantoku Nagakawa, Masaaki Hidaka, Takanobu Hara, Hajime Matsushima, Hajime Imamura, Takayuki Tanaka, Tomohiko Adachi, Akihiko Soyama, Kengo Kanetaka, Susumu Eguchi, Jincheng Wang
    PLOS ONE.2023; 18(11): e0293593.     CrossRef
  • Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis
    Seunghwan Shin, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Diagnostics.2022; 12(2): 441.     CrossRef
  • Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa
    Jeanne Perpétue Vincent, Gibril Ndow, Shintaro Ogawa, Amie Ceesay, Ramou Njie, Bakary Sanneh, Ignatius Baldeh, Umberto D’Alessandro, Maimuna Mendy, Mark Thursz, Isabelle Chemin, Yasuhito Tanaka, Maud Lemoine, Yusuke Shimakawa
    Journal of Global Health.2022;[Epub]     CrossRef
  • A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy
    Chien-Hung Chen, Tsung-Hui Hu, Jing-Houng Wang, Hsueh-Chou Lai, Chao-Hung Hung, Sheng-Nan Lu, Cheng-Yuan Peng
    Cancers.2022; 14(20): 5063.     CrossRef
  • External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals
    Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Journal of Viral Hepatitis.2021; 28(6): 951.     CrossRef
  • Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
    Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim
    Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123.     CrossRef
  • Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
    Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
    Journal of Viral Hepatitis.2021; 28(11): 1570.     CrossRef
  • Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
    Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, Hye Jung Shin, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Cancers.2021; 13(23): 5892.     CrossRef
  • Usefulness of Mac-2 binding protein glycosylation isomer in non-invasive probing liver disease in the Vietnamese population
    Thuy Thi Thu Pham, Dat Tan Ho, Toan Nguyen
    World Journal of Hepatology.2020; 12(5): 210.     CrossRef
  • Wisteria floribunda agglutinin-positive Mac-2-binding protein as a diagnostic biomarker in liver cirrhosis: an updated meta-analysis
    Shu Feng, Zhonghao Wang, Yanhua Zhao, Chuanmin Tao
    Scientific Reports.2020;[Epub]     CrossRef
  • Novel biomarkers for the management of chronic hepatitis B
    Takako Inoue, Yasuhito Tanaka
    Clinical and Molecular Hepatology.2020; 26(3): 261.     CrossRef
  • 8,813 View
  • 202 Download
  • 21 Web of Science
  • Crossref

Case Report

Vascular disorders of liver

Peliosis hepatis presenting with massive hepatomegaly in a patient with idiopathic thrombocytopenic purpura
Sun Bean Kim, Do Kyung Kim, Sun Jeong Byun, Ji Hye Park, Jin Young Choi, Young Nyun Park, Do Young Kim
Clin Mol Hepatol 2015;21(4):387-392.
Published online December 24, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.4.387

Peliosis hepatis is a rare condition that can cause hepatic hemorrhage, rupture, and ultimately liver failure. Several authors have reported that peliosis hepatis develops in association with chronic wasting disease or prolonged use of anabolic steroids or oral contraceptives. In this report we describe a case in which discontinuation of steroid therapy improved the condition of a patient with peliosis hepatis. Our patient was a 64-year-old woman with a history of long-term steroid treatment for idiopathic thrombocytopenic purpura . Her symptoms included abdominal pain and weight loss; the only finding of a physical examination was hepatomegaly. We performed computed tomography (CT) and magnetic resonance imaging (MRI) of the liver and a liver biopsy. Based on these findings plus clinical observations, she was diagnosed with peliosis hepatis and her steroid treatment was terminated. The patient recovered completely 3 months after steroid discontinuation, and remained stable over the following 6 months.

Citations

Citations to this article as recorded by  Crossref logo
  • Peliosis Hepatis Complicated by Scleroderma and Rapidly Progressing to Liver Failure
    Satoru Hagiwara, Hiroshi Ida, Takaaki Chikugo, Yoriaki Komeda, Naoshi Nishida, Akihiro Yoshida, Tomoki Yamamoto, Takuya Matsubara, Masatoshi Kudo
    Internal Medicine.2024; 63(23): 3171.     CrossRef
  • Editorial for “MRI of Peliosis Hepatis: A Case Series Presentation With a 2022 Systematic Literature Update”
    Christopher D. Brammer, Ilana A. Kafer, Jeffrey H. Maki
    Journal of Magnetic Resonance Imaging.2023; 58(5): 1406.     CrossRef
  • MRI of Peliosis Hepatis: A Case Series Presentation With a 2022 Systematic Literature Update
    Linda Calistri, Cosimo Nardi, Vieri Rastrelli, Davide Maraghelli, Luigi Grazioli, Luca Messerini, Stefano Colagrande
    Journal of Magnetic Resonance Imaging.2023; 58(5): 1386.     CrossRef
  • Imaging presentation and postoperative recurrence of peliosis hepatis: A case report
    Si-Xie Ren, Pan-Pan Li, Hai-Peng Shi, Jun-Hui Chen, Zhen-Ping Deng, Xi-E Zhang
    World Journal of Clinical Cases.2021; 9(19): 5197.     CrossRef
  • Psoriatic arthritis associated with peliosis hepatis: characteristics and therapeutic management
    Maroua Slouma, Yasmine Khrifech, Rim Dhahri, Emna Hannech, Zeineb Tayeb, Amen Ghozzi, Leila Metoui, Imen Gharsallah, Bassem Louzir
    Clinical Rheumatology.2021; 40(9): 3827.     CrossRef
  • Hepatic complications of oral contraceptive pills and estrogen on MRI: Controversies and update - Adenoma and beyond
    Janardhana Ponnatapura, Ania Kielar, Lauren M.B. Burke, Mark E. Lockhart, Abdul-Rahman Abualruz, Rafel Tappouni, Neeraj Lalwani
    Magnetic Resonance Imaging.2019; 60: 110.     CrossRef
  • Huge peliosis hepatis mimicking cystic echinococcosis
    JinHeng Liu, YanTin Wang, SiNeng Yin, NengWen Ke, XuBao Liu
    Medicine.2019; 98(51): e18141.     CrossRef
  • Gottron’s acrogeria and peliosis hepatis
    GC Ramirez, ML Rodriguez, AG Garcia, MR Cancio-Suarez, LA Viteri
    Global Journal of Rare Diseases.2019; 4(1): 017.     CrossRef
  • A case of multiple spontaneous hepatic ruptures and literature review
    N. V. Tytarenko, O. V. Sergiychuk
    Perioperaciina Medicina.2018; 1(1): 60.     CrossRef
  • 19,610 View
  • 157 Download
  • 7 Web of Science
  • Crossref

Liver Pathologys

Hepatic neoplasm

Sarcomatoid cholangiocarcinoma with osteoclast-like giant cells associated with hepatolithiasis: A case report
Hye Min Kim, Haeryoung Kim, Young Nyun Park
Clin Mol Hepatol 2015;21(3):309-313.
Published online September 30, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.3.309

Citations

Citations to this article as recorded by  Crossref logo
  • Hepatic Undifferentiated Carcinoma With Osteoclast Like Giant Cell With Dominant Intraductal Growth: A Case Report With Literature Review
    Yu-Chien Ko, Tse-Ching Chen
    International Journal of Surgical Pathology.2025; 33(8): 1784.     CrossRef
  • Ultrasonographic features and blood biochemistry findings of cholangiocarcinoma in a captive polar bear (Ursus maritimus)
    Keita Kakisaka, Nozomu Yokoyama, Fuka Takahashi, Keisuke Aoshima, Mitsuyoshi Takiguchi
    Veterinary Record Case Reports.2025;[Epub]     CrossRef
  • Contrast-enhanced ultrasound features of hepatic sarcomatoid carcinoma different from hepatocellular carcinoma
    Qiannan Zhao, Zhengbiao Ji, Yanling Chen, Kun Wang, Yijie Qiu, Xiaofan Tian, Yuli Zhu, Hong Qin, Hong Han, Haixia Yuan, Yi Dong, Wenping Wang
    Clinical Hemorheology and Microcirculation.2024; 87(1): 55.     CrossRef
  • A case of rapidly progressing sarcomatous intrahepatic cholangiocarcinoma with suddenly appearing lymph node metastasis
    Eisho Kanemitsu, Rei Takahashi, Setsuko Nakanishi, Satoru Sueyoshi, Atsushi Kobayashi, Takao Nishimura, Hiromitsu Nagata
    Surgical Case Reports.2024;[Epub]     CrossRef
  • Recent Advances in Pathology of Intrahepatic Cholangiocarcinoma
    Joon Hyuk Choi, Swan N. Thung
    Cancers.2024; 16(8): 1537.     CrossRef
  • Rare histotypes of epithelial biliary tract tumors: A literature review
    Elena Sapuppo, Oronzo Brunetti, Dalila Tessitore, Giovanni Brandi, Nicola Di Giovanni, Guido Fadda, Claudio Luchini, Maurizio Martini, Davide Quaresmini, Antonio Russo, Mariacarmela Santarpia, Aldo Scarpa, Mario Scartozzi, Giovanni Tuccari, Tindara Franch
    Critical Reviews in Oncology/Hematology.2023; 181: 103892.     CrossRef
  • Системна хiмiотерапiя при нерезектабельнiй формi внутрiшньопечiнкової саркоматоїдної холангiокарциноми: клiнiчний випадок та огляд лiтератури
    O.V. Hrуnenko, Iu.I. Zaivelieva, V.O. Kropelnytskyi, O.M. Ostapyshen, D.O. Fedorov
    Practical oncology.2023; 6(1): 35.     CrossRef
  • First report on establishment and characterization of the extrahepatic cholangiocarcinoma sarcoma cell line CBC2T-2
    Ning-Zu Jiang, Ming-Zhen Bai, Chong-Fei Huang, Ze-Long Ma, Ru-Yang Zhong, Wen-Kang Fu, Long Gao, Liang Tian, Ning-Ning Mi, Hai-Dong Ma, Ya-Wen Lu, Zi-Ang Zhang, Jin-Yu Zhao, Hai-Ying Yu, Bao-Ping Zhang, Xian-Zhuo Zhang, Yan-Xian Ren, Chao Zhang, Yong Zhan
    World Journal of Gastroenterology.2023; 29(41): 5683.     CrossRef
  • Sarcomatoid hepatocellular carcinoma versus conventional hepatocellular carcinoma: a systematic review and meta-analysis
    Tian-Run Lv, Hai-Jie Hu, Parbatraj Regmi, Fei Liu, Fu-Yu Li
    Journal of Cancer Research and Clinical Oncology.2022; 148(7): 1685.     CrossRef
  • Recurrent hepatocellular carcinoma with osteoclast-like giant cells: a case report
    Mone Tsukimoto, Kazushi Sugimoto, Ryuta Shigefuku, Ryosuke Sugimoto, Hiroto Yuasa, Katsunori Uchida, Norihiko Yamamoto
    Journal of Medical Case Reports.2022;[Epub]     CrossRef
  • Undifferentiated Carcinoma with Osteoclast-Like Giant Cells of the Common Bile Duct: A Case Report of a Rare Entity at an Unusual Location
    Chuan-Han Chen, Hsin-Ni Li
    Diagnostics.2022; 12(7): 1517.     CrossRef
  • Clinical diagnosis and treatment strategies for sarcomatoid intrahepatic cholangiocarcinoma
    Xia Sheng, Jian-Min Qin
    World Chinese Journal of Digestology.2022; 30(14): 614.     CrossRef
  • Intrahepatic sarcomatoid cholangiocarcinoma: A case report of the youngest patient on record and a review of the condition's characteristics
    Long-Fu Xi, Yun Jin, Jiang-Tao Li
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Osteoclasts in Tumor Biology: Metastasis and Epithelial-Mesenchymal-Myeloid Transition
    Kemal Behzatoglu
    Pathology and Oncology Research.2021;[Epub]     CrossRef
  • Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis
    Tao Wang, Junjie Kong, Xianwei Yang, Shu Shen, Menglan Zhang, Wentao Wang
    Journal of Surgical Oncology.2020; 121(3): 524.     CrossRef
  • Sarcomatoid intrahepatic cholangiocarcinoma mimicking liver abscess: A case report
    Yan Wang, Jia-Lei Ming, Xing-Yu Ren, Lu Qiu, Li-Juan Zhou, Shu-Dong Yang, Xiang-Ming Fang
    World Journal of Clinical Cases.2020; 8(1): 208.     CrossRef
  • Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma
    Jian-Ping Wang, Zhi-Gang Yao, Ya-Wen Sun, Xi-Han Liu, Feng-Kai Sun, Cun-Hu Lin, Fu-Xin Ren, Bei-Bei Lv, Shuai-Jun Zhang, Yang Wang, Fan-Ying Meng, Shun-Zhen Zheng, Wei Gong, Jun Liu
    World Journal of Gastroenterology.2020; 26(29): 4327.     CrossRef
  • Sarcomatoid intrahepatic cholangiocarcinoma in a patient with poor prognosis: a case report and literature review
    Xu Li, Jian Li, Kai Liu, Ludong Tan, Yahui Liu
    Journal of International Medical Research.2020;[Epub]     CrossRef
  • Analysis of intrahepatic sarcomatoid cholangiocarcinoma: Experience from 11 cases within 17 years
    Dong Kyun Kim, Bo Ra Kim, Jin Sook Jeong, Yang Hyun Baek
    World Journal of Gastroenterology.2019; 25(5): 608.     CrossRef
  • Intrahepatic Sarcomatous Cholangiocarcinoma: Case Report and Review of the Literature
    Thana Boonsinsukh, Vichit Viriyaroj, Thammanij Rookkachart, Therdkiat Trongwongsa
    Case Reports in Surgery.2018; 2018: 1.     CrossRef
  • A Case of Hepatic Angiosarcoma with Osteoclast-like Giant Cells
    Takahiro MIZUI, Keigo MURAKAMI, Yasuyuki HARA, Shigehito MIYAGI, Takeshi NAITOH, Michiaki UNNO, Takashi KAMEI
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2018; 79(2): 382.     CrossRef
  • Primary intrahepatic cholangiocarcinoma with sarcomatous stroma: case report and review of the literature
    Kyohei Yugawa, Tomoharu Yoshizumi, Yohei Mano, Noboru Harada, Shinji Itoh, Toru Ikegami, Yuji Soejima, Nobuhiro Fujita, Kenichi Kohashi, Shinichi Aishima, Yoshinao Oda, Masaki Mori
    Surgical Case Reports.2018;[Epub]     CrossRef
  • Intrahepatic sarcomatoid cholangiocarcinoma
    Sara Sintra, Rui Costa, Carlos Filipe, Adélia Simão
    BMJ Case Reports.2018; 2018: bcr-2018-225017.     CrossRef
  • Validation of difficulty scoring system for laparoscopic liver resection in patients who underwent laparoscopic left lateral sectionectomy
    Chami Im, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, YoungRok Choi, Jae Yool Jang, Hanlim Choi, Jae Seong Jang, Seong Uk Kwon
    Surgical Endoscopy.2017; 31(1): 430.     CrossRef
  • 12,203 View
  • 91 Download
  • 21 Web of Science
  • Crossref

Liver fibrosis, cirrhosis, and portal hypertension

Budd-Chiari syndrome with multiple large regenerative nodules
Haeryoung Kim, Ji Hae Nahm, Young Nyun Park
Clin Mol Hepatol 2015;21(1):89-94.
Published online March 25, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.1.89

Citations

Citations to this article as recorded by  Crossref logo
  • Characteristics of Regenerative Nodules and Their Relationship with Hepatocellular Carcinoma in Budd-Chiari Syndrome, and Role of Computed Tomography in Diagnosis and Follow-Up
    Umut Tüysüz, İmam Bakır Batı
    Indian Journal of Surgery.2024; 86(1): 172.     CrossRef
  • Budd‐Chiari syndrome in children: Radiological intervention and role of shear wave elastography in monitoring response
    Arghya Samanta, Anshu Srivastava, Rajnikant Yadav, Aditya Kapoor, Anindya Ghosh, Prabhakar Mishra, Moinak Sen Sarma, Ujjal Poddar
    Journal of Pediatric Gastroenterology and Nutrition.2024; 78(1): 17.     CrossRef
  • Masquerading Spleen: A Perplexing Case of Intrahepatic Splenosis Mimicking Hepatocellular Carcinoma
    Noriko Ikeda, Yujo Kawashita, Masaki Tateishi, Takashi Ueda, Junzo Yamaguchi, Yasuo Washida, Yoichi Hachitanda
    Cureus.2024;[Epub]     CrossRef
  • Focal Liver Lesions in Budd-Chiari Syndrome: Spectrum of Imaging Findings
    Francesco Rizzetto, Davide Rutanni, Luca Alessandro Carbonaro, Angelo Vanzulli
    Diagnostics.2023; 13(14): 2346.     CrossRef
  • Diagnostic challenges and risk stratification of hepatocellular adenoma
    Dana Balitzer, Sanjay Kakar
    Diagnostic Histopathology.2022; 28(2): 89.     CrossRef
  • Cardiovascular Disease in Primary Sjögren’s Syndrome: Raising Clinicians’ Awareness
    Mihnea Casian, Ciprian Jurcut, Alina Dima, Ancuta Mihai, Silviu Stanciu, Ruxandra Jurcut
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Parenchymal Extinction Mimicking Hepatocellular Carcinoma in a Patient with Chronic Hepatitis B-Related Liver Cirrhosis
    Min Kyu Kang, Joon Hyuk Choi
    Diagnostics.2021; 11(7): 1171.     CrossRef
  • Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)
    Akash Shukla, Ananta Shreshtha, Amar Mukund, Chhagan Bihari, C. E. Eapen, Guohong Han, Hemant Deshmukh, Ian Homer Y. Cua, Cosmas Rinaldi Adithya Lesmana, Mamun Al Meshtab, Masayoshi Kage, Roongruedee Chaiteeraki, Sombat Treeprasertsuk, Suprabhat Giri, Sun
    Hepatology International.2021; 15(3): 531.     CrossRef
  • Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis
    Virginia Hernández-Gea, Andrea De Gottardi, Frank W.G. Leebeek, Pierre-Emmanuel Rautou, Riad Salem, Juan Carlos Garcia-Pagan
    Journal of Hepatology.2019; 71(1): 175.     CrossRef
  • Benign and malignant hepatocellular lesions in patients with vascular liver diseases
    Valérie Vilgrain, Valérie Paradis, Morgane Van Wettere, Dominique Valla, Maxime Ronot, Pierre-Emmanuel Rautou
    Abdominal Radiology.2018; 43(8): 1968.     CrossRef
  • Hepatocellular nodules in vascular liver diseases
    Christine Sempoux, Charles Balabaud, Valérie Paradis, Paulette Bioulac-Sage
    Virchows Archiv.2018; 473(1): 33.     CrossRef
  • Budd-Chiari Syndrome: What Pathologists Need to Know About Hepatic Venous Outflow Obstruction
    Meredith E. Pittman
    AJSP: Reviews and Reports.2018; 23(5): 228.     CrossRef
  • Ruptured hepatocellular carcinoma in a child with Budd-Chiari syndrome
    Anandini Suri, Varun K. Sharma, Prajakta R. Ranade, Shaji Marar, Aabha Nagral
    Indian Pediatrics.2016; 53(9): 833.     CrossRef
  • 10,797 View
  • 113 Download
  • 11 Web of Science
  • Crossref

Case Reports

A case of isolated metastatic hepatocellular carcinoma arising from the pelvic bone
Kyu Sik Jung, Kyeong Hye Park, Young Eun Chon, Sa Ra Lee, Young Nyun Park, Do Yun Lee, Jin Sil Seong, Jun Yong Park
Korean J Hepatol 2012;18(1):89-93.
Published online March 22, 2012
DOI: https://doi.org/10.3350/kjhep.2012.18.1.89

Reports of metastatic hepatocellular carcinoma (HCC) without a primary liver tumor are rare. Here we present a case of isolated HCC that had metastasized to the pelvic bone without a primary focus. A 73-year-old man presented with severe back and right-leg pain. Radiological examinations, including computed tomography (CT) and magnetic resonance imaging (MRI), revealed a huge mass on the pelvic bone (13×10 cm). He underwent an incisional biopsy, and the results of the subsequent histological examination were consistent with metastatic hepatocellular carcinoma. The tumor cells were positive for cytokeratin (AE1/AE3), hepatocyte paraffin 1, and glypican-3, and negative for CD56, chromogranin A, and synaptophysin on immunohistochemical staining. Examination of the liver by CT, MRI, positron-emission tomography scan, and angiography produced no evidence of a primary tumor. Radiotherapy and transarterial chemoembolization were performed on the pelvic bone, followed by systemic chemotherapy. These combination treatments resulted in tumor regression with necrotic changes. However, multiple lung metastases developed 1 year after the treatment, and the patient was treated with additional systemic chemotherapy.

Citations

Citations to this article as recorded by  Crossref logo
  • A case of complete response to radiotherapy combined with durvalumab and tremelimumab in a patient with unknown primary hepatocellular carcinoma arising in the lumbar spine
    Aiko Tanaka, Tomokazu Kawaoka, Shinsuke Uchikawa, Hatsue Fujino, Atsushi Ono, Eisuke Murakami, Clair Nelson Hayes, Daiki Miki, Masataka Tsuge, Shiro Oka
    Clinical Journal of Gastroenterology.2025; 18(1): 107.     CrossRef
  • Hepatocellular carcinoma presenting as an extrahepatic mass: A case report and review of literature
    Wei Kelly Wu, Krutika Patel, Chandrasekhar Padmanabhan, Kamran Idrees
    World Journal of Gastrointestinal Oncology.2024; 16(5): 2241.     CrossRef
  • Solitary extrahepatic hepatocellular carcinoma in vertebrae without a primary lesion in the liver might originate from bone marrow: a case report and new hypothesis based on a review of the literature and the latest findings
    Yukihiro Shirota, Yoshimichi Ueda, Katsuaki Sato, Yasuhito Takeda, Yuji Hodo, Tokio Wakabayashi
    Clinical Journal of Gastroenterology.2022; 15(6): 1115.     CrossRef
  • Chest Wall Swelling in a Baby Boomer: An Unusual Presentation of Primary Hepatocellular Carcinoma
    Venkata Vinod Kumar Matli, Amina Dhahri, Venkatasai Boda Eswara, Linda D Green
    Cureus.2021;[Epub]     CrossRef
  • Foot and Ankle Hepatocellular Carcinoma Metastasis
    Kalind Parashar, Neeta Pandit-Taskar
    Clinical Nuclear Medicine.2016; 41(1): 69.     CrossRef
  • High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinoma
    Taehyung Kim, Hye Jung Cha, Jun Won Kim, Jinsil Seong, Ik Jae Lee
    Oncotarget.2016; 7(33): 53921.     CrossRef
  • Hepatocellular Carcinoma with Cervical Spine and Pelvic Bone Metastases Presenting as Unknown Primary Neoplasm
    Seawon Hwang, Jieun Lee, Jung Min Lee, Sook Hee Hong, Myung-Ah Lee, Hoo Geun Chun, Ho Jong Chun, Sung Hak Lee, Eun Sun Jung
    The Korean Journal of Gastroenterology.2015; 66(1): 50.     CrossRef
  • Metastatic hepatocellular carcinoma to the pelvis and vertebrae in a patient with chronic hepatitis ‘C’ with unknown primary
    Syed Hussain Abbas, Muhammad Zia Ul Islam Khan, Muhammad Ijaz, Syed Jawad Akhtar Hussain
    BMJ Case Reports.2015; 2015: bcr2014207249.     CrossRef
  • Using qualitative methods to develop a contextually tailored instrument: Lessons learned
    Haeok Lee, Peter Kiang, Minjin Kim, Semira Semino-Asaro, Mary E Colten, Shirley S Tang, Phala Chea, Sonith Peou, Dorcas C Grigg-Saito
    Asia-Pacific Journal of Oncology Nursing.2015; 2(3): 192.     CrossRef
  • Mediastinal Hepatocellular Carcinoma with Unknown Primary: An Unusual and Rare Presentation
    Peng Soon Koh, Mastura Md Yusof, Boon Koon Yoong, Pathmanathan Rajadurai
    Journal of Gastrointestinal Cancer.2014; 45(S1): 74.     CrossRef
  • 9,362 View
  • 45 Download
  • Crossref
Hepatogastric fistula caused by direct invasion of hepatocellular carcinoma after transarterial chemoembolization and radiotherapy
Hana Park, Seung Up Kim, Junjeong Choi, Jun Yong Park, Sang Hoon Ahn, Kwang-Hyub Han, Chae Yoon Chon, Young Nyun Park, Do Young Kim
Korean J Hepatol 2010;16(4):401-404.
Published online December 31, 2010
DOI: https://doi.org/10.3350/kjhep.2010.16.4.401

A 63-year-old man with a history of hepatitis-B-related hepatocellular carcinoma (HCC) in the left lateral portion of the liver received repeated transcatheter arterial chemoembolization (TACE) and salvage radiotherapy. Two months after completing radiotherapy, he presented with dysphagia, epigastric pain, and a protruding abdominal mass. Computed tomography showed that the bulging mass was directly invading the adjacent stomach. Endoscopy revealed a fistula from the HCC invading the stomach. Although the size of the mass had decreased with the drainage through the fistula, and his symptoms had gradually improved, he died of cancer-related bleeding and hepatic failure. This represents a case in which an HCC invaded the stomach and caused a hepatogastric fistula after repeated TACE and salvage radiotherapy.

Citations

Citations to this article as recorded by  Crossref logo
  • Unusual upper gastrointestinal bleeding following radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma
    CW Chang, HW Wang, WH Huang, PH Chuang
    Journal of Postgraduate Medicine.2023; 69(4): 237.     CrossRef
  • Hepatic artery pseudo-aneurysm rupturing into hepato-gastric fistula, a rare cause of massive upper gastrointestinal hemorrhage: Case report
    Arkadeep Dhali, Avik Sarkar, Sukanta Ray, Dijendra Nath Biswas, Gopal Krishna Dhali, Ankit Mahajan
    Radiology Case Reports.2022; 17(1): 133.     CrossRef
  • Hepatocellular Carcinoma with Gastrointestinal Involvement: A Systematic Review
    Cristiana Marinela Urhut, Larisa Daniela Sandulescu, Liliana Streba, Vlad Florin Iovanescu, Sarmis Marian Sandulescu, Suzana Danoiu
    Diagnostics.2022; 12(5): 1270.     CrossRef
  • Malignant hepatogastric fistula with associated secondary liver abscess: a rare complication of an occult gastric adenocarcinoma
    Alexander Mimery, Nicolas Ramly, Amitabha Das, Kheman Rajkomar
    BMJ Case Reports.2021; 14(8): e240238.     CrossRef
  • Upper Gastrointestinal Bleed Due to Invasive Hepatocellular Carcinoma and Hepato-Gastric Fistula
    Abhijith Bale, Shiran Shetty, Anurag Shetty, Girisha Balaraju, Cannanore Ganesh Pai
    Journal of Clinical and Experimental Hepatology.2018; 8(1): 104.     CrossRef
  • Gastric Metastasis of Hepatocellular Carcinoma With Gastrointestinal Bleeding After Liver Transplant: A Case Report
    L. Li, W.H. Zhang, F.P. Meng, X.M. Ma, L.J. Shen, B. Jin, H.W. Li, J. Han, G.D. Zhou, S.H. Liu
    Transplantation Proceedings.2015; 47(8): 2544.     CrossRef
  • Hepatoduodenal fistula formation following transcatheter arterial chemoembolization and radiotherapy for hepatocellular carcinoma: treatment with endoscopic Histoacryl injection
    Jaryong Jeon, Joonseong Ahn, Hongseok Yoo, Taek Kyu Park, Dongmo Je, Hyemin Jeong, Kwang Hyuck Lee
    The Korean Journal of Internal Medicine.2014; 29(1): 101.     CrossRef
  • Hepatogastric fistula: a rare complication of pyogenic liver abscess
    Venkata Srinivas Gandham, Biju Pottakkat, Lakshmi C Panicker, Ranjit Vijaya Hari
    BMJ Case Reports.2014; 2014: bcr2014204175.     CrossRef
  • 9,166 View
  • 64 Download
  • Crossref
Liver Pathology
Massive hepatic necrosis with large regenerative nodules
Haeryoung Kim, Young Nyun Park
Korean J Hepatol 2010;16(3):334-337.
Published online September 30, 2010
DOI: https://doi.org/10.3350/kjhep.2010.16.3.334

Citations

Citations to this article as recorded by  Crossref logo
  • Human liver regeneration following massive hepatic necrosis: Two distinct patterns
    Katalin Dezső, Péter Nagy, Sándor Paku
    Journal of Gastroenterology and Hepatology.2020; 35(1): 124.     CrossRef
  • Interpretation of core biopsy of liver mass lesions: A comparison study between cytopathologist and gastrointestinal pathologist
    Erik R. Washburn, Zhaohai Yang
    Annals of Diagnostic Pathology.2019; 40: 152.     CrossRef
  • Modulation of the extrinsic cell death signaling pathway by viral Flip induces acute-death mediated liver failure
    Miriam Bittel, Andreas E. Kremer, Michael Stürzl, Stefan Wirtz, Iris Stolzer, Markus F. Neurath, Gianna Ballon, Claudia Günther
    Cell Death & Disease.2019;[Epub]     CrossRef
  • 9,590 View
  • 55 Download
  • Crossref